首页 | 本学科首页   官方微博 | 高级检索  
     


Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia
Authors:Laura Cesini  Camilla Frieri  Claudia Baratè  Federica Sorà  Massimiliano Bonifacio  Marco Cerrano  Antonia Cagnetta  Chiara Elena  Lara Aprile  Nicola Sgherza  Malgorzata Trawinska  Antonella Gozzini  Isabella Capodanno  Monica Crugnola  Ida Carmosino  Emilia Scalzulli  Federica Ricci  Monica Bocchia  Micaela Bergamaschi  Chiara Aguzzi  Simona Sica  Sara Galimberti  Massimo Breccia  Luigiana Luciano  Roberto Latagliata
Affiliation:1. Department of Translational and Precision Medicine, University “La Sapienza” of Rome, Rome, Italy;2. Hematology, University “Federico II” of Neaples, Naples, Italy;3. Department of Clinical and Experimental Medicine – Hematology, University of Pisa, Pisa, Italy;4. Hematology, Catholic University of Sacred Heart of Rome, Rome, Italy;5. Department of Medicine, Section of Hematology, University of Verona, Verona, Italy;6. Department of Oncology and Hematology, University of Turin, Turin, Italy;7. Clinical Hematology, Policlinico San Martino, Genua, Italy;8. Hematology, San Matteo Hospital, Pavia, Italy;9. Division of Hematology, University of Siena, Siena, Italy;10. Hematology, IRCCS, "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy;11. Hematology, Sant’Eugenio Hospital, Rome, Italy;12. Hematology, University of Florence, Florence, Italy;13. Hematology, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy;14. Hematology, University of Parma, Parma, Italy
Abstract:
Keywords:chronic myeloid leukemia  erythropoietin  imatinib  late anemia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号